Lexicon Pharmaceuticals | LXRX - Market Capitalization


Lexicon Pharmaceuticals reported $406.3M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 312M 115M Mar/2026
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Coherus Biosciences USD 183M 11M Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 475M 410M Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Lexicon Pharmaceuticals USD 416M 2M Mar/2026
MacroGenics USD 192M 90M Mar/2026
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024